Banff 2013分类对无急性功能障碍的同种异体移植物中疑似与确诊晚期抗体介导排斥反应诊断的影响
研究对68例肾移植受者的73份指征性活检按Banff 2013重新分类,18%的诊断类别发生变化,确诊ABMR比例从Banff 2009的40%升至Banff 2013的74%(P=0.006),但未检测供者特异性抗体或未行超微结构检查的慢性ABMR组织学病例可能被不充分描述。
要点
- Banff 2013使18%的活检诊断类别改变,主要涉及Category 2病例。
- 确诊ABMR比例Banff 2009为40%,Banff 2013为74%(P=0.006)。
- 未检测HLA供者特异性抗体或未行超微结构检查时,慢性ABMR组织学病例可能被不充分描述。
核心结论
- Banff 2013分类有助于诊断晚期ABMR,识别病例,减少疑似ABMR比例并做出更确诊的诊断。
研究设计与样本
- 回顾性研究,纳入68例肾移植受者的73份指征性肾移植活检(因慢性功能障碍、蛋白尿和/或新发供者特异性抗体),初始按Banff 2009分类,后按Banff 2013重新分类。
主要发现
- Banff 2013使18%的研究活检诊断类别发生变化。
- 重新分类主要涉及Category 2病例,其中23.5%来自较年长且移植物功能更差患者的活检被Banff 2009漏诊。
- Banff 2009标准下13%的病例排除ABMR。
- 确诊ABMR比例Banff 2009为40%,Banff 2013为74%(P=0.006),因纳入微血管炎症并接受部分超微结构诊断标准。
关键数值与推荐
- 按Banff 2013标准,未检测人类白细胞抗原供者特异性抗体或未行超微结构检查时,有慢性ABMR组织学征象的样本可能被不充分描述。
临床怎么用
- 原文未据此给出推荐。
局限性
- 按新分类标准,未检测人类白细胞抗原供者特异性抗体或未行超微结构检查时,有慢性ABMR组织学征象的样本可能被不充分描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Banff classification is used worldwide to characterize pathological findings in renal allograft biopsies. During the 11th Banff meeting, relevant changes were introduced in the diagnostic criteria for Category 2 antibody-mediated rejection (ABMR). Here, we assess the effect of these changes on the diagnosis of late chronic ABMR. METHODS: Seventy-three indication renal graft biopsies (chronic dysfunction, proteinuria and/or the presence of de novo donor-specific antibodies) from 68 kidney transplant recipients initially classified following the Banff 2009 criteria were reviewed and reclassified as per the new Banff 2013 criteria. RESULTS: The diagnostic category changed in 18% of the study biopsies with Banff 2013. The reclassification mainly involved Category 2 cases, from which 23.5% of the biopsies from older patients with worse graft function were overlooked by Banff 2009. ABMR was ruled out in 13% of cases under the Banff 2009 criteria. A significant number of the study samples were conclusively diagnosed as ABMR (40% as per Banff 2009 and 74% as per Banff 2013; P = 0.006), because of the inclusion of microvascular inflammation and the acceptance of some ultrastructural diagnostic criteria. However, when following the criteria of the new classification, samples with histological signs of chronic ABMR, in which human leucocyte antigen donor-specific antibodies are not detected or ultrastructural studies are not performed, may be inadequately characterized. CONCLUSIONS: The Banff 2013 classification helps in making a diagnosis of late ABMR, identifying cases, decreasing the percentage of suspected ABMR and making more conclusive diagnoses.
引用
- Gimeno J, Redondo D, Pérez-Sáez MJ, et al. Impact of the Banff 2013 classification on the diagnosis of suspicious versus conclusive late antibody-mediated rejection in allografts without acute dysfunction. Nephrol Dial Transplant. 2016. PMID: 27312147
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。